Ferring
A Principal DMPK Scientist at Ferring Pharmaceuticals specializes in the strategy and interpretation of drug metabolism and pharmacokinetics data. They support drug development projects by managing studies, providing scientific guidance, and engaging with regulatory authorities in a collaborative, research-driven environment.
Company Size
1-10 employees
Ferring Pharmaceuticals is a research-driven, specialty biopharmaceutical company committed to helping people build families and live better lives. In the United States, Ferring is a leader in reproductive medicine, uro-oncology, and specialty areas within orthopaedics and gastroenterology, including microbiome therapeutics. The company develops and markets innovative therapies across these focus areas and operates in more than 50 countries with over 6,000 employees worldwide.
Ferring Highlights New Real-World Research with ADSTILADRIN
Oct 28, 2025
Ferring Unveils New Data with ADSTILADRIN® (nadofaragene firadenovec-vncg) at 112th Annual Meeting of the Japanese Urological Association
Apr 21, 2025
Ferring opens doors to Finnish manufacturing hub as supply of its bladder cancer gene therapy continues to grow
Oct 3, 2024
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Ferring.
Ferring didn’t post a salary, so this is our estimate from similar listings.
U.S. FDA Approves Second Drug Product Manufacturing Facility for ADSTILADRIN® (nadofaragene firadenovec-vncg)
Apr 24, 2025